These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4918701)

  • 1. Thyroid as an adjuvant to amphetamine therapy of obesity. A controlled double-blind study.
    Kaplan NM; Jose A
    Am J Med Sci; 1970 Aug; 260(2):105-11. PubMed ID: 4918701
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-blind trial of anorectic agents.
    Sproule BC
    Med J Aust; 1969 Feb; 1(8):394-5. PubMed ID: 4889477
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectiveness of weight reduction involving "diet pills".
    Asher WL; Dietz RE
    Curr Ther Res Clin Exp; 1972 Aug; 14(8):510-24. PubMed ID: 4629313
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of phentermine-amphetamine resin complex with sustained-release dextroamphetamine and placebo in the treatment of exogenous obesity.
    De Felice EA; Cohen A; Schmitz PL; Rothwell KG; Truant AP
    J Clin Pharmacol J New Drugs; 1968; 8(6):360-9. PubMed ID: 4883784
    [No Abstract]   [Full Text] [Related]  

  • 5. [By the authority of the Commission de Thérapeutique. On the subject of treatment of obesity by a combination of amphetamine and desiccated thyroid gland].
    Laroche G
    Bull Acad Natl Med; 1969; 153(1):34-6. PubMed ID: 4893155
    [No Abstract]   [Full Text] [Related]  

  • 6. [The problem of drug therapy in obesity].
    Liebermeister H
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1393-8. PubMed ID: 1030003
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of dextro-amphetamine and racemic-amphetamine in the treatment of the hyperkinetic syndrome or minimal brain dysfunction.
    Gross MD
    Dis Nerv Syst; 1976 Jan; 37(1):14-6. PubMed ID: 1106966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levoamphetamine and dextroamphetamine: comparative efficacy in the hyperkinetic syndrome. Assessment by target symptoms.
    Arnold LE; Wender PH; McCloskey K; Snyder SH
    Arch Gen Psychiatry; 1972 Dec; 27(6):816-22. PubMed ID: 4564954
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential effect of amphetamine optical isomers on Bender Gestalt performance of the minimally brain dysfunctioned.
    Arnold LE; Huestis RD; Wemmer D; Smeltzer DJ
    J Learn Disabil; 1978 Mar; 11(3):127-32. PubMed ID: 353207
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction of low-dose amphetamine use with schizophrenia in outpatients: three case reports.
    West AP
    Am J Psychiatry; 1974 Mar; 131(3):321-3. PubMed ID: 4812699
    [No Abstract]   [Full Text] [Related]  

  • 11. The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study.
    Childress AC; Brams M; Cutler AJ; Kollins SH; Northcutt J; Padilla A; Turnbow JM
    J Child Adolesc Psychopharmacol; 2015 Jun; 25(5):402-14. PubMed ID: 25692608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of drugs in the treatment of obesity.
    Gershberg H
    Postgrad Med; 1972 May; 51(5):135-8. PubMed ID: 5025213
    [No Abstract]   [Full Text] [Related]  

  • 13. Double-blind comparison of efficacy, safety, and side effects of Bionamin, phentermine compound, and placebo in the treatment of exogenous obesity.
    Cohen A; De Felice EA; Leb SM; Fuentes JG; Rothwell KG; Truant AP
    Curr Ther Res Clin Exp; 1968 Jul; 10(7):323-34. PubMed ID: 4969672
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine, psychomotor stimulants, and schizophrenia: effects of methylphenidate and the stereoisomers of amphetamine in schizophrenics.
    Janowsky DS; Davis JM
    Adv Biochem Psychopharmacol; 1974; 12(0):317-23. PubMed ID: 4608582
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of obesity.
    Penick SB; Stunkard AJ
    Adv Psychosom Med; 1972; 7():217-28. PubMed ID: 4573726
    [No Abstract]   [Full Text] [Related]  

  • 16. Intractable obesity and its complications. Treatment with intramuscular dextro-amphetamine sulfate.
    Gilbert DB
    Rocky Mt Med J; 1965 Nov; 62(11):53-4 passim. PubMed ID: 5835779
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of impotence with methyltestosterone thyroid (100 patients--double blind study).
    Jakobovits T
    Fertil Steril; 1970 Jan; 21(1):32-5. PubMed ID: 4903799
    [No Abstract]   [Full Text] [Related]  

  • 18. Obesity--the health hazard of our time.
    Sedgwick JP
    S Afr Med J; 1971 Apr; 45(14):362-70. PubMed ID: 4930511
    [No Abstract]   [Full Text] [Related]  

  • 19. False-Positive Findings on Dopamine Transporter SPECT Due to Therapeutic Dextroamphetamine and Amphetamine.
    Frankl JA; Bose S; Kuo PH
    J Nucl Med Technol; 2018 Jun; 46(2):149-150. PubMed ID: 29273699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [When and how to prescribe thyroid hormones].
    Merchie G
    Rev Med Liege; 1969 Jun; 24(11):445-51. PubMed ID: 5401859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.